Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)Yuankai Shi, Qian Wang, Zhen Wang et al.|Journal of Hematology & Oncology|2021Cited by 64